Metabolic Diseases Completed Phase 1 Trials for Bococizumab (DB12456)

Also known as: Diseases, Metabolic / Metabolic Disease

IndicationStatusPhase
DBCOND0030621 (Metabolic Diseases)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01435382A Pharmacokinetic and Pharmacodynamic Study of PF-04950615 (RN316) in Subjects With HypercholesterolemiaBasic Science